ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[MEF2C, COL4A1, TACSTD2, LGR4]
GO:0032330;regulation of chondrocyte differentiation;6.0;0.7671156992804218;0.7066781622303554;9.34084218004034;56.03372000150423;5.948432231191374;0.001875398181376348;0.6273234135236593;[AXIN2, ADAMTS12, RUNX2, CTGF, HOXA11, LOXL2, GREM1, POR, EFEMP1, SNAI2]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[PHB2, TNF, CLU, PYCARD, AKT1, TNFSF11, BTK, PRKCQ, S100A8, CARD11, BEX1, TNFRSF11A, NHLH2, NLRP3, S100A12, FZD1, TGFB1, JUP, NFKB1, IL6, COPS5, JMY, MYD88, CD40, ITGB2, CD36, IL10, MYOCD, EDN1, CHUK, ANXA3, DDX58, NFAM1, IRAK3, TRAF1, GREM1, PSMA6, IL1B, KIT, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0060401;cytosolic calcium ion transport;9.0;0.7248374789738407;0.7586593646672094;8.986670366319727;37.619827487335996;5.459585514144159;0.0012591017703544919;0.675444082270312;[FASLG, SLC8A1, CTGF, JPH2, CCR7, CCL19, CCR5, CCL21, PRKCE, F2R, PTPRC, LCK, FKBP1B, XCL1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, S100A12, TGFB1, NFKB1, MYD88, CD40, ITGB2, CD36, CHUK, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, EPB41L3, TLN1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, GREM1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0002634;regulation of germinal center formation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;44.47967864407596;7.57984905034425;0.0014886948151053528;0.738553198190834;[MEF2C, BCL6, TNFAIP3, PKN1, TNFSF13B]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, IHH, ENG, CTGF]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[MEF2C, PTGS2, KLF4]
GO:0071374;cellular response to parathyroid hormone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.57984905034425;0.003661012767841448;0.710754145523778;[MEF2C]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0018277;protein deamination;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;151.15475272427284;9.777073627680469;0.005059013543235805;0.8509193652572005;[LOXL1]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[BRCA2, CTGF, TK1, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, DTL, BLM, PCNA, POLD3, POLD1, RPA1, POLA1, POLA2, RAD50, CENPF, POLE2, RPA3]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[IHH, DLL1, MEF2C, STIL, ENG]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, SIRT1]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, KCNH2, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, LCP2, LCP1, DTL, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, CD40, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EGF, MAPK14, TEK, CYFIP1, EPS8, STMN1, CYP1B1, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, ADM, IFIH1, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, CSPG4, LAT, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, NOD2, RAB21, PLN, PML, DNAJA3, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, TGFB1, JUP, PRKCD, MAPK14, IFNG, CDK1]
GO:0060998;regulation of dendritic spine development;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;87.62706980140223;5.572381008289503;0.002932799167010087;0.7002128357670632;[NLGN1, LRRK2, FMR1, MEF2C, PLK2, CAMK1, SHANK3]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0048251;elastic fiber assembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.541318973862396;7.474488534686424;0.0013234123611784638;0.7053660038532718;[MFAP4, EFEMP2, MYH11, EMILIN1, LOXL1]
GO:0045540;regulation of cholesterol biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;116.98845768213258;6.039404009397101;0.0039154983958446;0.705096027081865;[ELOVL6, POR, SCD, RAN]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, NINJ1, TEK]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, EPB41L3, SFN, FN1, NRP1, CDKN1A, ARHGAP4, ESM1, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, IGFBP3, S100A8, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, RAB21, SEMA4B, PML]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, NCKAP1L, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, KCNH2, CAMK2D, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0034059;response to anoxia;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.16160540946;8.67846133901236;7.082598888462125E-4;0.7340579283277371;[CTGF]
GO:0070278;extracellular matrix constituent secretion;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;23.0991473088411;8.67846133901236;7.731076725439974E-4;0.7669372290569613;[ENG, CTGF]
GO:0070318;positive regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;82.71654658760917;8.390779266560578;0.002768448374228408;0.7800242071602487;[CTGF]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[TNFAIP3, PTPRK, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, PCNA, FOXO1, PDGFD, ECT2, JUN, KLF4, IL6, CDK1, EZH2]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0060025;regulation of synaptic activity;7.0;1.0;0.8509193652572005;9.628524252492122;30.61939422688933;8.67846133901236;0.001024803569108247;0.7947362817240173;[MEF2C]
GO:1904753;negative regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;245.4091710939714;7.9853141584524145;0.008213624102600289;0.8046099625986299;[MEF2C, MYOCD, TPM1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, ADM, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, RARA, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, IL23A, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CCR2, IL10, EDN1, SYK, RHOG, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PURA, PAK1, CXCR2, CDX2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, IHH, AXIN2, MAPK14, RUNX2, BMP2]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, RARA, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, IRX3, FKBP1B, CAMK1]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, BCL3, CD28, CD24, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, DCC, PAWR, TNFRSF1B, SIRT1, IFNG, IL1B, TLR4, PPP1R15A, BCL2A1, IFI6, PERP, E2F1, E2F2, CASP8AP2, SORT1, G0S2, MLH1, POU4F1, PML]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, ABCB4, GATA3, SLC30A10, GATA1, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, FZD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, GPR37, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, GPNMB, NTF3, FLNA, CCL19, CCL21, GABRA5, POU4F1, PF4, TNF, CLU, CTGF, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, SOCS2, PSAP, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, BCL3, CDK1, MYD88, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, DNAJA3, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, SOX4, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, CD34, IL10, EDN1, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, IHH, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, GREM1, NDUFS3, IRF7, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[MEF2C, CXCL9, TNFSF14, IGFBP3, FLT3LG, MAPK14]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, RARA, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, BCL3, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, IL23A, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, PRL, BRCA1, CD3D, IL10, EDN1, RGMA, IL1B, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, CAMK1, IL17A, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, POU4F1, NR4A2, NR4A3]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MEF2C, MYOCD, EDNRB]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0051385;response to mineralocorticoid;7.0;0.7980440201809971;0.7499413753476991;9.36615998802463;62.73690238121479;6.280566066213989;0.00209974766315278;0.6721078059595746;[CDKN1A, EDN1, AVPR1A, FOS, CTGF, FOSB]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, CD3E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, THY1, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, PTPN6, MNDA]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, CD3E, MAP1B]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[MEF2C, TGFB1, JUP, KLF4, THBS1]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[NLGN1, MCTP1, LRRK2, FMR1, SNCA, MEF2C, CHRNB4, KMO]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0060536;cartilage morphogenesis;4.0;0.8436909121759173;0.6718454560879586;9.158520623246385;27.732136419115502;6.481236761676141;9.281696486453839E-4;0.5814507494004503;[MEF2C, COL14A1, COL6A2, COL12A1, COL6A3, HOXA5]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, FYN, CSK, LYN, SYK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0048667;cell morphogenesis involved in neuron differentiation;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;47.452274261266446;7.212124270218933;0.0015881849152503491;0.6919486831672181;[MEF2C, SLITRK6, SLC1A3]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, FMR1, IHH, MEF2C, ETV1, THY1, NPY, TGFB2, GABRA5, LIF, POU4F1, SLC4A7, UQCRQ]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, LY96, CD14, CARD9, NFKB1, NFKBIA, BCL3]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, NCKAP1L, PKN1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, TWIST1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0050982;detection of mechanical stimulus;4.0;0.7369933605727446;0.6184966802863723;8.712233520617966;57.71052606361059;5.9928839937622085;0.0019315193712475664;0.5564763661386056;[CXCL12, JUP, DENND5B, COL11A1, KIT, FYN, SCN1A]
GO:0002587;negative regulation of antigen processing and presentation of peptide antigen via MHC class II;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;144.69507589410327;9.083926447120524;0.004842813973061743;0.8154717862087246;[HLA-DOA, HLA-DOB]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, BCL3, CXCL13]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, IL10, MIF, AURKB, BCL6, BTK]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, LOXL1, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0050867;positive regulation of cell activation;5.0;0.5557027117453593;0.5680923677336;7.431299675155902;42.06625563378019;3.805811787890007;0.0014079197188904481;0.48487040368196277;[, TFRC, LGALS1, MYB, TRBC1, RPS6KA1, AKT1, TNFSF11, ICOSLG, MEF2C, FLT3LG, MIF, IL23A, BTK, PRKCQ, HHLA2, GATA3, CD1D, THY1, KLRK1, INPP5D, NCKAP1L, IGHA1, ICOS, LYN, EGR3, TNFSF14, TNFSF13, BST1, VNN1, CD28, CD24, CD320, IGHM, CDKN1A, CD40, CD3E, CTLA4, CCR7, CCR2, HLA-DPA1, HAVCR2, IL10, ANXA1, FCER1G, SYK, FCRL3, PDCD1LG2, VAV1, IL1B, IGHD, RARA, TLR6, TLR4, PTAFR, UNG, PAK1, HLA-DMB, IGKC, PDPN, CCL19, IL12RB1, CCL21, LILRB1, LILRB2, MLH1, CD40LG, HLA-DPB1, CD86, CD83, CD80, SIRPG, MPL, IHH, CTGF, PYCARD, IGHG1, GRAP2, IL6R, CD177, PDGFRB, ATP11C, MSH6, MSH2, CARD11, CD274, BLM, CORO1A, DPP4, BTLA, STAP1, NLRP3, TGFB1, VCAM1, CAV1, SELP, IL6, PTPRC, NR4A3, BCL6, ITGAM, LRRK2, ITGB2, SIRPB1, TNFSF13B, DUSP10, FGR, ZAP70, IFNG, LCK, XCL1, NOD2, THBS1, HSPD1, CCL5, CCL2, FYN, CSK, CD2, CD4, CD6, DNAJA3, PTPN6]
GO:0032012;regulation of ARF protein signal transduction;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;48.758993290020136;6.943860283624253;0.0016319196251719597;0.7513499630073597;[PSD3]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[CD83, TNF, PYCARD, HERC5, CDH3, DHX58, HOMER3, GHSR, CD96, LAG3, IL1R2, SLC11A1, IL23A, BTK, CD274, TWIST1, GATA3, INPP5D, NLRP3, HMOX1, NCKAP1L, ELANE, TGFB2, TGFB1, PRG2, FN1, INHBA, NFKB1, IL6, BCL6, BCL3, CD24, GPR18, ORM1, IFNA2, TNFAIP3, PTPN22, LRRC32, IFIH1, CD34, HAVCR2, IL10, ANXA1, ARG1, DDX58, IRAK3, PDCD1LG2, CEACAM1, IFNG, BANK1, RARA, TLR8, XCL1, BPI, TLR6, TLR4, LTF, DLL1, THBS1, GPNMB, CSK, LILRB1, KLF4, PML, NLRP12, FCGR2B, LGR4]
GO:0086073;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;6.0;1.0;0.8231203125901445;9.628524252492122;24.262698198658363;7.9853141584524145;8.120506736983656E-4;0.7314896500084853;[DSP, JUP]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:0007172;signal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;86.36830501999869;7.697632086000634;0.002890669442591265;0.7167775754447168;[CD3E, PTK2]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD, RARA]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, GATA1, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, SATB2, FLNA, CDX2, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, FEV, MAFF, MYOCD, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF5, POU2AF1, TAF5, RBMX]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[CTGF, FGF5, FLRT2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, KIF16B, ESRP1]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[NUP62, MCCC2, CHRNB4, CLDN3, COL6A2, NUP54, NLGN1, CTNNA1, RRM1, JUP, GCH1, COL1A1, COL1A2, P2RX1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, MED23, RARA, YAP1, TAF9, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1, TAF5]
GO:1903966;monounsaturated fatty acid biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;557.0401903451324;9.083926447120524;0.018643633867227657;0.8797934328124444;[SCD]
GO:0002159;desmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;75.07953051527643;8.390779266560578;0.0025128443191556717;0.7522251544931926;[JUP, PKP3]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[SLC8A1, CTGF, LGALS1, SOX4, MEN1, RMI1, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, FKBP1B, NOX4]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[EGR1, MEF2C, EGR2, PAX5, FOS, KLF5, MAFF, ATF3]
GO:0048167;regulation of synaptic plasticity;7.0;0.6729672293956388;0.6874029799550199;8.567652291806858;39.259689615435484;4.623782033182691;0.0013139864800018823;0.5873797934620173;[MCTP1, FMR1, NRGN, CDC20, GRM5, TNR, EPHB2, YWHAH, MEF2C, SORCS3, KIT, RARA, SHANK3, CX3CR1, SLC24A2, SLC24A1, NLGN1, PTGS2, SNCA, EGR2, PLK2, LILRB2]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, GATA1, PTPN6]
GO:2000311;regulation of AMPA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.558197802812269;0.006718796083723233;0.7316271658034954;[MEF2C, NLGN1, ADRB2, SHANK3]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1, DAPK1, EPHB2]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MEF2C, JUN]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, LAT]
GO:0010694;positive regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.71736046966464;7.9853141584524145;0.01056677592774235;0.8236103492792612;[MEF2C]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[MEF2C, EZH2]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[MEF2C, NLGN1, LRRK2, GRIK3, PTGS2, KMO, ADCYAP1, GRM5, CNR1, TNR, SHANK3]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, BMP2, LTF]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[ROBO2, NLGN1, AMIGO3, THBS2, FLRT2, SLITRK6, EPHB2, EPHB1, SNCA, GHSR, MEF2C, LRRN3, PTK2, TLR2]
GO:0046949;fatty-acyl-CoA biosynthetic process;7.0;0.7866048967936545;0.7442218136540277;9.352270875863963;404.0761203118406;6.409777797693995;0.01352406410193885;0.6787156999164222;[ACSL1, TECR, ACSL5, ELOVL6, ELOVL7, ACAT1, SCD, ACSBG1]
GO:0014033;neural crest cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;46.51447820026907;7.9853141584524145;0.001556797725050427;0.6986103492792611;[MEF2C, FRZB]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[SOX4, MEF2C, RUNX2, SHANK3, CSF1R, FZD1, JAG1, BCL11B, FZD5, FZD8, INHBA, USH2A, POU4F1, NR4A2, ID1, ITM2C]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, EREG, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, NCKAP1L]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[GREM1, MEF2C, MYOCD, EDN1, TGFB1]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, SOX4, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, KIT, BLM, GATA3, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, DNAJA3, BCL3, CD28, GPR18, IL18R1]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[FASLG, TNF, CYR61, CTGF, PYCARD, CTSH, SOX7, DAPK1, F2R, SIRT1, F3, IFI27, LCK, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, GSN, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[CD86, CD83, SLC46A2, CD80, IFNA2, IHH, DUSP10, MYB, CTLA4, HLA-DOA, CR1, ANXA1, SYK, ZAP70, IFNG, IL23A, FANCD2, IL1B, RARA, CARD11, GATA3, CLPTM1, NLRP3, NCKAP1L, CCL19, IL12RB1, TGFB1, EGR3, LILRB2, CD2, VNN1, BCL6, CAMK4, CD28]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, EDN1, TGFB1, ARG1, CAV1, COL1A1, COL4A2, NOX4, XCL1]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, JUN, NR2F2, PKIG, EZH2, SIRT1, MMP12, BTAF1, FLNA, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, CIITA, LRRK2, FHL2, FASLG, HHEX, ITGB8, PEG3, BIRC5, E2F1, FYN, E2F7, PRRX1, EIF3E, UXT, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, PCBP3, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, LOXL2, CCNE1, CALCA, CCNB1, VDR, CAV1, HMGA1, BMP2, MXD1, HMGB2, MYOCD, GREM1, ELF3, IRF7, FBP1, AURKB, SERPINE1, PHB2, MYB, HOXA2, HOXA7, DAPK1, HOXB4, HOXB3, SERPING1, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, SNAI2, CDKN1A, HAVCR2, PAWR, PAX5, PAX2, AES, RARA, GAS1, ENG, ASCL2, NR1H2, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, NACC2, WFS1, LSM5, LSM3, BCL6, CNOT3, BCL3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, EDN1, CBFA2T3, NME1, MDFIC, PURA, CDX2, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, H2AFX, IFNG, PFDN5, THBS1, SNCA, MEIS2, RBMX]
GO:0002721;regulation of B cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;107.63791932510406;9.777073627680469;0.003602544291973033;0.875;[BTK]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, CKS2, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, CXCL10, MYD88, CIITA, FHL2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, EPHB2, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, BRCA1, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, IL10, RGMA, IL1B, KIT, YAP1, SATB2, IL17A, CD86, CD80, IHH, ACTG2, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, ENG, EPCAM, GSN, NR1H2, GTF2H1, POU4F1, PLP1, FOSB, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, MDFIC, TLR6, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:2001016;positive regulation of skeletal muscle cell differentiation;9.0;0.8653626801206646;0.8289219652406215;9.541512875502493;376.2972035421309;7.9853141584524145;0.01259432875705866;0.8046099625986299;[MEF2C]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, CTGF, RUVBL2, PDGFRB, IL10, GHSR, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, EPHB2, PHLDA2, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IL10, EDN1, GREM1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0035984;cellular response to trichostatin A;6.0;1.0;0.8231203125901445;9.628524252492122;367.2586666355552;8.390779266560578;0.012291817060950673;0.7522251544931926;[MEF2C, EZH2]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, EPB41L3, FLNA, TSPAN5, JUP, TSPAN15, EHD3, RAMP1]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, PRG2, GATA3, CD3E, CD40LG, CD28, RARA, NLRP3, PRKCQ, HAVCR2]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, PDGFRA, EDN1, CHUK, ARG1, MMP2, COL4A1, NAIP, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, COL5A2]
GO:0090073;positive regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.416497719221994;7.57984905034425;0.0015869875065849188;0.710754145523778;[MEF2C]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, IL1B, SATB2, CDX2, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, IRF7, FBP1, AURKB, SNCA, MEIS2]
GO:0018057;peptidyl-lysine oxidation;9.0;1.0;0.896240625180289;9.628524252492122;320.93714865322556;8.16763571524637;0.010741477540741758;0.8139338954918922;[LOXL1, LOXL2]
GO:0098911;regulation of ventricular cardiac muscle cell action potential;10.0;0.7866048967936545;0.8085434602577476;9.537552474286395;102.35229487303722;7.138016298065211;0.0034256391983155283;0.7802794972956796;[DSP, JUP, KCNE3, CAV1]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[PID1, TNC, CTGF, ALAD, AKT1, FFAR2, CCR7, CD36, PTGDR, EDN1, DGAT2, ACSL1, PRKCE, NME1, TGFBR3, IL1B, TLR2, PTGER2, PTAFR, PTGS2, P2RY6, CCNB1, E2F1, CCL19, CCL21]
GO:0060297;regulation of sarcomere organization;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;165.46881499726612;7.8311634786251565;0.005538092325693202;0.7967266896635242;[MEF2C, EDN1]
GO:0060452;positive regulation of cardiac muscle contraction;9.0;0.811012628672052;0.801746939516315;9.466005322994347;171.4016794204555;7.379178354882098;0.005736659958706022;0.7736121494158466;[KCNQ1, CTGF]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, GNAI1, CCL7, CTNNA1, FYN, KLF4, RAD51, CD69]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, JUN, HACE1, NR2F2, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, CIITA, FHL2, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, LOXL2, HMGA1, MXD1, HMGB2, AFF3, LYL1, NUP62, MYOCD, ETV1, ELF3, IRF7, CREB5, TAF9, MAPK14, TAF5, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, PURA, CDX2, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, COL4A2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0045597;positive regulation of cell differentiation;5.0;0.4493394816318884;0.5149107526768645;6.573475401781711;82.53300662006848;2.970244267288293;0.0027623054566900678;0.44213944182052767;[CYFIP1, SERPINE1, MYB, AKT1, HOXA5, MEF2A, MEF2C, SPINT1, MAP1B, AGTR1, HOXB4, GATA3, GATA1, EPB41L5, PRDM16, SFN, NCKAP1L, LYN, FZD1, JUN, JAG1, FN1, COL1A1, EZH2, TGFB1I1, ADM, TIMP2, ANXA1, FOS, SIRT1, PAX2, RARA, ENG, PTGS2, FRZB, FLNA, CCL19, IL12RB1, TMEM64, POU4F1, PF4, PLXND1, FMR1, TNF, CTGF, CDH5, SEMA6A, IGFBP3, ATP11C, OLFM4, ADCYAP1, TACSTD2, SOCS2, NFKB1, CXCL12, BCL6, PLXNB2, CYR61, DUSP10, ADAMTS20, CX3CR1, NLGN1, SMARCD3, LRP2, RAB21, FYN, CTHRC1, IRX3, KLF5, CPNE5, RPS6KA1, TNFSF11, EPHB2, FLT3LG, RUNX2, BTC, SFRP4, POR, SFRP2, IL23A, BTK, EPHA3, TWIST1, INPP5D, CCR1, MSR1, EGR3, TNFSF14, LIF, VNN1, CD24, ROBO2, NRP1, CD36, CD34, CCR2, EDN1, SYK, NME1, CEACAM1, IL1B, KIT, TLR2, CXCR4, PAK1, PDPN, CTNNA1, CDX2, LILRB2, FKBP1B, CAMK1, IL17A, SCARB2, CD86, CD83, CD80, MPL, IHH, HOXA11, LOXL2, ARHGDIA, IL6R, LTBP3, NLRP3, ECT2, TGFB2, TGFB1, SYT2, VDR, INHBA, IL6, BMP2, LIN28A, FES, TCF4, DOCK5, CXCL9, HMGB2, TMEM100, MYOCD, AXIN2, DNM2, GREM1, ZAP70, IFNG, LTA, PDE5A, SHANK3, LTF, CNR1, MAPK14, CD4, ACIN1]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, IHH, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, EREG, BTK, CFTR, EPB42, GATA3, CCNB1, CCL19, FZD5, CCL21, NR4A2, FEV, SLC26A8, PLP1, SLC26A3]
GO:0072160;nephron tubule epithelial cell differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;49.624654608214016;9.083926447120524;0.0016608925304473024;0.7876727335416686;[MEF2C]
GO:0045879;negative regulation of smoothened signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;188.1075192762445;6.444869117505266;0.006295789384399518;0.6805102716434839;[CD3E, RUNX2, PRKACB]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT]
GO:0098761;cellular response to interleukin-7;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;9.777073627680469;0.0027327542132076126;0.8231203125901445;[BTK]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:2000987;positive regulation of behavioral fear response;7.0;1.0;0.8509193652572005;9.628524252492122;209.702758470375;8.16763571524637;0.007018562605773582;0.7686126355688037;[MEF2C]
GO:0002669;positive regulation of T cell anergy;8.0;1.0;0.875;9.628524252492122;417.44285307459876;8.67846133901236;0.013971436618229886;0.8188169164668168;[CD3E]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, NOD2, PAK1, CCL19, FZD5, CCL21, CARD9, FZD8, CD40LG, PKN1, LTBR, FCGR2B]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, HERC5, LGALS3, TRBC1, DHX58, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, S100A12, CD14, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, PML, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071864;positive regulation of cell proliferation in bone marrow;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.9853141584524145;0.0021103132289136558;0.7314896500084853;[MEF2C, FLT3LG]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, ECM1, TWIST1, TNF, GATA1, HOXA2, MEN1, CCR1, MEF2C, TGFB1, IGFBP5, TMEM64, AXIN2, GREM1, ID1]
